ID: ALA3356605

Max Phase: Preclinical

Molecular Formula: C31H43N9O6S

Molecular Weight: 669.81

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)c1nccs1

Standard InChI:  InChI=1S/C31H43N9O6S/c1-17(2)13-23(27(44)38-22(9-6-10-35-31(32)33)26(43)30-34-11-12-47-30)39-28(45)24(40-29(46)25(16-41)37-18(3)42)14-19-15-36-21-8-5-4-7-20(19)21/h4-5,7-8,11-12,15,17,22-25,36,41H,6,9-10,13-14,16H2,1-3H3,(H,37,42)(H,38,44)(H,39,45)(H,40,46)(H4,32,33,35)/t22-,23-,24-,25-/m0/s1

Standard InChI Key:  PHPJWSFXNNRMES-QORCZRPOSA-N

Associated Targets(Human)

Hepatocyte growth factor activator 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Matriptase 677 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serine protease hepsin 242 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 669.81Molecular Weight (Monoisotopic): 669.3057AlogP: 0.31#Rotatable Bonds: 18
Polar Surface Area: 244.28Molecular Species: BASEHBA: 9HBD: 9
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.57CX Basic pKa: 11.92CX LogP: -1.23CX LogD: -2.93
Aromatic Rings: 3Heavy Atoms: 47QED Weighted: 0.04Np Likeness Score: -0.03

References

1. Han Z, Harris PK, Jones DE, Chugani R, Kim T, Agarwal M, Shen W, Wildman SA, Janetka JW..  (2014)  Inhibitors of HGFA, Matriptase, and Hepsin Serine Proteases: A Nonkinase Strategy to Block Cell Signaling in Cancer.,  (11): [PMID:25408834] [10.1021/ml500254r]

Source